Table 1 Baseline characteristics of the randomised study population at 36 months.
Control (n = 391) | Intervention (n = 406) | P | |
|---|---|---|---|
Mean age at inclusion, years (SD) | 68.4 (10.9) | 67.3 (10.7) | NS |
Women (%) | 29.7 | 27.6 | NS |
Smokers (current and ex) (%) | 60.4 | 63.5 | NS |
Qualifying event | |||
UA (%) | 11.3 | 8.6 | NS |
NSTEMI (%) | 58.8 | 60.6 | NS |
STEMI (%) | 29.9 | 30.8 | NS |
Medical history | |||
Diabetes (%) | 17.9 | 18.7 | NS |
Atrial fibrillation (%) | 10.2 | 12.1 | NS |
Heart failure (%) | 0.8 | 1.7 | NS |
Myocardial infarction (%) | 16.4 | 14.5 | NS |
Stroke or transient ischaemic attack (%) | 5.6 | 6.2 | NS |
Baseline measurements | |||
SBP (mmHg) (SD) | 132 (19) | 131 (18) | NS |
DBP (mmHg) (SD) | 77 (11) | 77 (10) | NS |
LDL-C (SD) | 2.18 (0.8) | 2.18 (0.7) | NS |
